Resources / Kaleo

kaleo, Inc., Labeler Code 60842, Covered Outpatient Drugs Exclusively Available at the 340B Ceiling Price via Direct Customer Solutions, LLC

On January 2, 2023, kaleo, Inc. (“Kaleo”), labeler code 60842, began participating in the 340B Program under a newly executed Pharmaceutical Pricing Agreement. Kaleo has elected to offer its covered outpatient drug products sold under labeler code 60842 at the 340B Ceiling Price to qualifying 340B Covered Entities and their contract pharmacy agents exclusively via a direct distribution model through Kaleo’s third-party logistics provider Direct Customer Solutions, LLC (“DCS”). DCS will accept orders and provide logistics, invoicing, and customer support.

In order to purchase the selected products through DCS, an entity needs to register eligible site(s) by visiting www.directcustomersolutions.com. Covered Entities using a Third-Party Administrator (“TPA”) to manage orders and inventory may continue to use their current system if that TPA has previously registered with DCS. You may check with your TPA to determine if it is already registered with DCS, or you may visit the DCS website for a list of registered TPAs. If your TPA is not currently registered with DCS, you may contact DCS directly to facilitate the enrollment of your TPA, including Electronic Data Interchange (“EDI”) connectivity. Once registered, customers may place orders with DCS via EDI, online at www.directcustomersolutions.com, or by phone at (731) 574-2060.

Kaleo is fully committed to both patient safety and compliance with its Pharmaceutical Pricing Agreement with the Department of Health and Human Services and the statutory requirements for the 340B Program and is ensuring Kaleo covered outpatient drug products sold under labeler code 60842 are readily available at the 340B Ceiling Price via DCS.

If you have any questions regarding this model or access to these products, please contact DCS customer service at (731) 574-2060 or Kaleo customer service at customersupport@kaleo.com.